Skip to main content

Corporate insider profile

Dennis Podlesak Insider Trades

Latest reported as Director of Syndax Pharmaceuticals Inc (SNDX).

Purchase filings
0
Reported companies
1
Net open-market value
-$113,716.00
Latest transaction
Oct 29, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 29, 2026Syndax Pharmaceuticals Inc (SNDX)DirectorSale8,000$14.21$113,716